Looking for a Growth Stock? 3 Reasons Why Intuitive Surgical (ISRG) is a Solid Choice
π Intuitive Surgical (ISRG) is recommended by the Zacks Growth Style Score system due to its strong growth prospects and top Zacks Rank.
π° The company's historical EPS growth rate stands at 14.3%, with projected earnings growth expected to reach 16.5% this year.
π Intuitive Surgical's current projected EPS growth of 16.5% significantly surpasses the industry average of 12.3%.
π΅ Year-over-year cash flow growth for ISRG is currently at 15.8%, which contrasts sharply with the industry average of 0%.
π Historically, ISRG has achieved an annualized cash flow growth rate of 19.5% over the past 3-5 years compared to the industry's 7.5%.
π Upward revisions in earnings estimates for the current year have surged by 5.1% over the past month.
π Based on its favorable metrics, ISRG has earned a Growth Score of B and is assigned a Zacks Rank #2 (Buy).
π Stocks combining a Growth Score of A or B with a Zacks Rank of #1 or #2 historically demonstrate better returns than the market.
π€ The positive trend in earnings estimate revisions correlates strongly with near-term stock price movements for ISRG.
π Intuitive Surgical's financial strength allows it to expand its business without relying on expensive outside funds due to high cash flow growth.
π― Investors are advised that double-digit earnings growth is a key indicator of strong prospects and potential stock price gains.
π The full list of Zacks #1 Rank (Strong Buy) stocks is available for further review on Zacks Investment Research.
π This article originally published on Zacks Investment Research, suggesting readers consider their portfolio when evaluating this stock.
β οΈ While growth stocks carry above-average risk and volatility, ISRG is presented as a solid choice within that category.
π The proprietary Zacks system looks beyond traditional growth attributes to analyze real growth prospects for companies like Intuitive Surgical.
- Intuitive Surgical has earned a favorable Growth Score of B, supported by exceptionally surging profit levels that indicate strong prospects.
- The company is expected to grow EPS by 16.5% this year, which significantly crushes the industry average of 12.3%.
- Year-over-year cash flow growth for Intuitive Surgical is 15.8%, whereas the industry average stands at 0%, highlighting superior financial health.
- The company's annualized cash flow growth rate has been 19.5% over the past 3-5 years compared to an industry average of 7.5%.
- There have been upward revisions in current-year earnings estimates for Intuitive Surgical, with the Zacks Consensus Estimate surging 5.1% over the past month.
- Intuitive Surgical carries a top Zacks Rank #2 (Buy), positioning the stock well for outperformance and attracting growth investors.
- The article explicitly states that growth stocks "usually carry above-average risk and volatility," warning investors of potential instability.
- There is a significant risk if the growth story is found to be over or nearing its end, which could lead to "significant loss" for investors betting on Intuitive Surgical (ISRG).
- The Zacks Rank of #2 (Buy) suggests the stock may not possess the strongest buy signals compared to stocks with a #1 (Strong Buy) ranking.
- While the industry average EPS growth is cited as 12.3%, the article notes that double-digit earnings growth is only "preferable" rather than guaranteed for all growth investors, indicating room for potential underperformance relative to broader market expectations.